Deutsche Bank Maintains Hold on Cabot, Raises Price Target to $74

Deutsche Bank analyst David Begleiter maintains Cabot (NYSE:CBT) with a Hold and raises the price target from $65 to $74.

byBenzinga Newsdesk

May 17, 2022

1 minute read

Deutsche Bank analyst David Begleiter maintains Cabot (NYSE:CBT) with a Hold and raises the price target from $65 to $74.

Spirit Airlines Flies Higher After Merger Announcement: What’s Next?

By Tyler Bundy

Today, 3:35 AM

Spirit Airlines Inc. (NYSE: SAVE) shares are pushing higher after the company announced a merger agreement Monday with Frontier Group Holdings Inc (NASDAQ: ULCC).

SAVE

‘New FDA guidance on rapid tests w/Omicron…’ Mentions Abbott BinaxNOW antigen, Quidel QuickVue antigen, Meridian Bioscience Revogene single target test…Applied DNA Sciences Linea’ -Tweet From Nature Reporter

By Benzinga Newsdesk

Today, 3:35 AM

https://twitter.com/amymaxmen/status/1473736804352278538

ABT

Warner Music Group Launches Music World In Metaverse With Sandbox: What Investors Should Know

By Chris Katje

Today, 3:35 AM

One of the largest music publishers is pushing into the metaverse with a partnership with a leading digital land company. Here’s the details and what it could mean in the future.

RBLX

B. Riley Securities Upgrades Infinera to Buy, Raises Price Target to $11.5

By Benzinga Newsdesk

Today, 3:35 AM

B. Riley Securities analyst Dave Kang upgrades Infinera (NASDAQ:INFN) from Neutral to Buy and raises the price target from $10 to $11.5.

INFN

Deutsche Bank Maintains Hold on Cabot, Raises Price Target to $74

Related Posts

Spirit Airlines Flies Higher After Merger Announcement: What’s Next?

‘New FDA guidance on rapid tests w/Omicron…’ Mentions Abbott BinaxNOW antigen, Quidel QuickVue antigen, Meridian Bioscience Revogene single target test…Applied DNA Sciences Linea’ -Tweet From Nature Reporter

Warner Music Group Launches Music World In Metaverse With Sandbox: What Investors Should Know

B. Riley Securities Upgrades Infinera to Buy, Raises Price Target to $11.5